CClinicalTrials.gg
Status unknownNCT03804281Updated Jan 18, 2019

Clinical Evaluation of Conventional Versus Microsurgical Techniques of Esthetic Crown Lengthening

An interventional study of Test group and Control group in Gummy Smile, sponsored by Cairo University. Status unknown. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-18.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

the study compare gingival margin stability following conventional approach versus microsurgical approach of esthetic crown lengthening in management of patients with short clinical crowns in the upper anterior region.In management of patients with short clinical crowns in the upper anterior region, there is no difference in gingival margin stability between conventional and microsurgical approaches of esthetic crown lengthening.

02

Conditions studied

  • Gummy Smile
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients with healthy systemic condition.
  • Adult patients ˃ 18 years old.
  • The presence of the six upper anterior teeth.
  • Absence of sites with attachment loss and probing depth (PD) >3 mm
  • Keratinized gingiva of at least 2mm width.
  • Compliance with good oral hygiene.
  • Patients accepts 6-months follow-up period (cooperative patients).
  • Patients provides an informed consent

Exclusion criteria

Exclusion Criteria:

  • Gummy smile with normal tooth proportions
  • Presence of prosthetic crowns
  • Extensive restorations
  • Extensive incisal edge attrition.
  • Misalignment on maxillary anterior teeth.
  • Smokers ˃ 10 cigarettes / day.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Test group

    esthetic crown lengthening with microsurgical approach

    Procedure: Test group

  • Active comparator
    Control group

    esthetic crown lengthening with conventional approach.

    Procedure: Control group

Interventions

  • ProcedureTest group

    The surgery will be done with the use of 4x magnification loop, the knives are micro blades and micro-sutures 7//0 used with the microsurgical instruments kit

  • ProcedureControl group

    esthetic crown lengthening with conventional approach with an internal bevel incision, following CEJ anatomy, this will be followed by an intra-sulcular incision, removal of the strip of outlined marginal gingiva and elevation of a mucoperiosteal flap to the level of the alveolar bone crest.

06

What researchers measure

Primary outcomes

  1. Mid-buccal gingival margin level

    periodontal probe with William's graduation will be used to measure the distance from the CEJ to the gingival margin at the mid-buccal surface

    Time frame: 6 months

Secondary outcomes

  1. Pink Esthetic Score (PES)

    The PES is based on seven variables: mesial papilla, distal papilla, soft-tissue level, soft tissue contour, alveolar process deficiency, soft-tissue color and texture. Each variable shall be assessed with a 2-1-0 score, with 2 being the best and 0 being the poorest score. The mesial and distal papilla will be evaluated for completeness, incompleteness or absence

    Time frame: 6 months

  2. Post-Surgical swelling

    will be evaluated post-surgically with Verbal Rating Scale with words ranging from (absent-slight-moderate-intense) Absent (no swelling), Slight (intraoral swelling at the operated area), Moderate (moderate intraoral swelling at the operated area) and Intense (intensive extra oral swelling extending beyond the operated area).

    Time frame: 7days

  3. Post-Surgical Patient Satisfaction: 3-item questionnaire

    A 3-item questionnaire is asked and the patients shall use a 7-point answer scale

    Time frame: 6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03804281
Lead sponsor
Cairo University
Responsible party
Mohamed elshafie mohamed tawfiq hassan (Dentist, Cairo University) — Principal investigator
First posted
Jan 15, 2019
Start date
Feb 1, 2019 (estimated)
Primary completion
Jan 1, 2020 (estimated)
Completion
Aug 1, 2020 (estimated)
Last update
Jan 18, 2019

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion